MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
dc.contributor.author | Ways, D. Kirk | en_US |
dc.contributor.author | Kukoly, Cynthia A. | en_US |
dc.contributor.author | DeVente, James E. | en_US |
dc.contributor.author | Hooker, Jerry L. | en_US |
dc.contributor.author | Bryant, Winifred O. | en_US |
dc.contributor.author | Posekany, Karla J. | en_US |
dc.contributor.author | Fletcher, Donald J. | en_US |
dc.contributor.author | Cook, Paul P. | en_US |
dc.contributor.author | Parker, Peter J. | en_US |
dc.date.accessioned | 2011-04-28T17:58:41Z | en_US |
dc.date.accessioned | 2011-05-17T00:25:40Z | |
dc.date.available | 2011-04-28T17:58:41Z | en_US |
dc.date.available | 2011-05-17T00:25:40Z | |
dc.date.issued | 1995-04 | en_US |
dc.description.abstract | Increased protein kinase C (PKC) activity in malignant breast tissue and positive correlations between PKC activity and expression of a more aggressive phenotype in breast cancer cell lines suggest a role for this signal transduction pathway in the pathogenesis and/or progression of breast cancer. To examine the role of PKC in the progression of breast cancer, human MCF-7 breast cancer cells were transfected with PKC-a, and a group of heterogenous cells stably over expressing PKC-a were isolated (MCF-7-PKC- a).MCF-7-PKC-a cells expressed five fold higher levels of PKC-a as compared to parental or vector-transfected MCF- 7 cels. MCF-7-PKC-a cells also displayed a substantial increase in endogenous expression of PKC-8 and decreases in expression of the novel 6- and q-PKC isoforms. MCF-7-PKC-a cells displayed an enhanced proliferative rate, anchorage-independent growth, dramatic morphologic alterations including loss of an epithelioid appearance, and increased tumorigenicity in nude mice. MCF-7-PKC- a cells exhibited a significant reduction in estrogen receptor expression and decreases in estrogen-dependent gene expression. These findings suggest that the PKC pathway may modulate progression of breast cancer to a more aggressive neoplastic process. Originally published Journal of Clinical Investigation, Vol. 95, No. 4, Apr 1995 | en_US |
dc.identifier.citation | Journal of Clinical Investigation; 95:4 p. 1906-1915 | en_US |
dc.identifier.doi | 10.1172/JCI117872 | |
dc.identifier.pmid | PMC295735 | en_US |
dc.identifier.uri | http://hdl.handle.net/10342/3403 | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | East Carolina University | en_US |
dc.relation.uri | http://www.jci.org/95/4 | en_US |
dc.rights | Author notified of opt-out rights by Cammie Jennings prior to upload of this article. | en_US |
dc.subject | PKC isoforms | en_US |
dc.subject | Vimentin | en_US |
dc.subject | Estrogen receptor | en_US |
dc.subject | Anchorage independent | en_US |
dc.subject | Tumorigenicity | en_US |
dc.title | MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MCF 7 breast cancer cells.pdf
- Size:
- 5.46 MB
- Format:
- Adobe Portable Document Format